BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang JJ, Zheng Y, Sun L, Wang L, Yu PB, Dong JH, Zhang L, Xu J, Shi W, Ren YC. TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis. Mol Biol Rep 2011;38:4847-53. [PMID: 21140221 DOI: 10.1007/s11033-010-0619-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Banday MZ, Sameer AS, Nissar S. Colorectal Cancer and Genetic Polymorphism in Key Regulatory Low Penetrance Genes. Genetic Polymorphism and cancer susceptibility 2021. [DOI: 10.1007/978-981-33-6699-2_5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Elshazli RM, Toraih EA, Elgaml A, Kandil E, Fawzy MS. Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies. Gene 2020;734:144391. [PMID: 32001373 DOI: 10.1016/j.gene.2020.144391] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
3 Zhang Y, Zhang D, Zhao L, Sun L, Dong Q, Cheng L, Cheng R. Association between p53 Arg72Pro polymorphism and colorectal cancer risk in Asian population: a meta-analysis. Current Problems in Cancer 2018;42:582-92. [DOI: 10.1016/j.currproblcancer.2018.08.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Elsaid A, Zahran R, Elshazli R, El-sayed A, Abou Samra M, El-tarapely F, Abdel-malak C. Genetic polymorphisms of TP53 Arg72Pro and Pro47Ser among Egyptian patients with colorectal carcinoma. Archives of Physiology and Biochemistry 2018;125:255-62. [DOI: 10.1080/13813455.2018.1453522] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tan SC. Low penetrance genetic polymorphisms as potential biomarkers for colorectal cancer predisposition. J Gene Med 2018;20:e3010. [PMID: 29424105 DOI: 10.1002/jgm.3010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
6 Tian X, Dai S, Sun J, Jiang S, Jiang Y. The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies. Oncotarget 2017;8:1156-65. [PMID: 27901479 DOI: 10.18632/oncotarget.13589] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
7 Iversen PL. CURE 2000. Molecular Basis of Resilience 2018. [DOI: 10.1007/978-3-319-98164-2_6] [Reference Citation Analysis]
8 Feng S, Rabii R, Liang G, Song C, Chen W, Guo M, Wei X, Messadi D, Hu S. The Expression Levels of XLF and Mutant P53 Are Inversely Correlated in Head and Neck Cancer Cells. J Cancer 2016;7:1374-82. [PMID: 27471552 DOI: 10.7150/jca.14669] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
9 Djansugurova L, Zhunussova G, Khussainova E, Iksan O, Afonin G, Kaidarova D, Parker MI. Association of DCC, MLH1, GSTT1, GSTM1, and TP53 gene polymorphisms with colorectal cancer in Kazakhstan. Tumour Biol. 2015;36:279-289. [PMID: 25249451 DOI: 10.1007/s13277-014-2641-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
10 Michopoulou V, Derdas SP, Symvoulakis E, Mourmouras N, Nomikos A, Delakas D, Sourvinos G, Spandidos DA. Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients. Tumour Biol 2014;35:12765-73. [PMID: 25213701 DOI: 10.1007/s13277-014-2604-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
11 Jing L, Su L, Ring BZ. Ethnic background and genetic variation in the evaluation of cancer risk: a systematic review. PLoS One. 2014;9:e97522. [PMID: 24901479 DOI: 10.1371/journal.pone.0097522] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
12 Lanara Z, Giannopoulou E, Fullen M, Kostantinopoulos E, Nebel JC, Kalofonos HP, Patrinos GP, Pavlidis C. Comparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection. Hum Genomics 2013;7:14. [PMID: 23738773 DOI: 10.1186/1479-7364-7-14] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
13 Feng X, Zhou HF, Zheng BS, Shi JJ, Luo C, Qin JJ. Association of glutathione S-transferase P1 gene polymorphism with the histological types of lung cancer: a meta-analysis. Mol Biol Rep 2013;40:2439-47. [PMID: 23184053 DOI: 10.1007/s11033-012-2324-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
14 Zhou T, Yin S, Qin Y. Association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease susceptibility. J Renin Angiotensin Aldosterone Syst 2013;15:22-31. [DOI: 10.1177/1470320312460898] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
15 Feng X, Zheng BS, Shi JJ, Qian J, He W, Zhou HF. Association of glutathione S-transferase P1 gene polymorphism with the susceptibility of lung cancer. Mol Biol Rep 2012;39:10313-23. [PMID: 23065248 DOI: 10.1007/s11033-012-1908-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
16 Chen J, Ma L, Peng NF, Wang SJ, Li LQ. A meta-analysis of the relationship between glutathione S-transferases gene polymorphism and hepatocellular carcinoma in Asian population. Mol Biol Rep. 2012;39:10383-10393. [PMID: 23053942 DOI: 10.1007/s11033-012-1917-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
17 Theodoratou E, Montazeri Z, Hawken S, Allum GC, Gong J, Tait V, Kirac I, Tazari M, Farrington SM, Demarsh A, Zgaga L, Landry D, Benson HE, Read SH, Rudan I, Tenesa A, Dunlop MG, Campbell H, Little J. Systematic Meta-Analyses and Field Synopsis of Genetic Association Studies in Colorectal Cancer. JNCI Journal of the National Cancer Institute 2012;104:1433-57. [DOI: 10.1093/jnci/djs369] [Cited by in Crossref: 79] [Cited by in F6Publishing: 85] [Article Influence: 7.9] [Reference Citation Analysis]
18 Zhang Y, Liu L, Tang Y, Chen C, Wang Q, Xu J, Yang C, Miao X, Wei S, Chen J, Nie S. Polymorphisms in TP53 and MDM2 contribute to higher risk of colorectal cancer in Chinese population: a hospital-based, case–control study. Mol Biol Rep 2012;39:9661-8. [DOI: 10.1007/s11033-012-1831-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
19 Tomlinson IP, Houlston RS, Montgomery GW, Sieber OM, Dunlop MG. Investigation of the effects of DNA repair gene polymorphisms on the risk of colorectal cancer. Mutagenesis. 2012;27:219-223. [PMID: 22294770 DOI: 10.1093/mutage/ger070] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]